Yeon-Soo Kim, Ph.D. Co-founder/CEO
With a Ph.D. from Seoul National University and postdoctoral research from the University of Wisconsin at Madison, Dr. Yeon-Soo Kim has made significant contributions to biotechnology and academia. Formerly a professor and distinguished research fellow at Chungnam National University, Dr. Kim also held leadership positions, including CEO of Vectorcore A, Ltd. His expertise in viral vector technology forms a strong foundation for our company's research and product development.
Dr. Sungsub Kim, Ph.D. Co-founder/Chief of Advisory Board
Dr. Sungsub Kim brings his Ph.D. from Cornell University and extensive experience in drug development to the team. As a former CEO of A&RT, Ltd. and head of research at YI Frontier, Dr. Kim has successfully led projects resulting in major partnerships and exports. His work in drug development with LG Life Sciences has generated substantial global sales and advances in treatment options. As our Chief Advisor, Dr. Kim guides our R&D efforts with deep industry insights and technical expertise.
Together, Drs. Yeon-Soo Kim and Sungsub Kim are leading our company toward a future where innovative biotechnology solutions address complex medical challenges worldwide.
Advisory Board and Partners for Clinical Trials
Our advisory board comprises esteemed experts across biotechnology, pharmaceutical development, and clinical research. Each advisor brings a wealth of experience from leading institutions and corporations, guiding our company in achieving groundbreaking advancements in the biotech field.
Dr. Sungsub Kim, Ph.D.
With extensive experience at LG Life Sciences, A&RT, and Chungnam National University, Dr. Sungsub Kim is a seasoned expert in drug development and biotechnology. He provides strategic insight into our R&D initiatives, leveraging his knowledge from years in leadership roles.
Dr. Soon-Jae Park, CEO/Ph.D.
Dr. Park, CEO at Alteogen, has a robust background in pharmaceutical innovation and corporate strategy. His expertise in biotechnology commercialization supports our growth and market entry strategies.
Dr. Jun-Min Go, M.D./Ph.D.
Currently associated with Asan Medical Center, Dr. Go has dedicated his career to medical research and clinical excellence. His perspective on healthcare delivery and clinical best practices strengthens our product development.
Jung-Min Kim CEO
CEO Jungmin Kim is a seasoned expert in biotech startup investment and corporate management. With a successful track record in guiding emerging biotech companies, he has held pivotal roles at Daesung Ventures and Megal Investment. His deep understanding of the biotech industry’s unique challenges and opportunities makes him an invaluable asset to our advisory board.
Heeyeon Kim, PM & RA
Heeyeon Kim brings her experience from LG Life Sciences, Arkgene Bioscience, and Schering, where she specialized in project management and regulatory affairs. She offers invaluable guidance on our clinical trial processes and ensures our projects meet global standards.
Dr. Doo-Sik Kong, M.D./Ph.D.
With a distinguished career at Samsung Medical Center, Dr. Kong is a highly regarded clinician and researcher in the field of neurosurgeon. His insights into clinical operations and patient-centered care enhance our approach to developing clinical trials.
Dr. Jeong-Hun Kim, M.D./Ph.D
Affiliated with Seoul National University Hospital, Dr. Kim has a wealth of experience in academic medicine and translational research in the field of Pediatric Ophthalmology. He advises us on bridging research and direct clinical application, ensuring our innovations address real-world healthcare needs.
